Insurer-PBM Firms Dominate Medicare Part D Market, Steering Patients to Their Pharmacies
Insurer-pharmacy benefit manager (PBM) firms control most of the Medicare Part D market, steering patients to their pharmacies through network exclusions and targeted marketing.
Read More
Frameworks for Advancing Health Equity: Accessing Ketamine-Assisted Therapy
Jessica Tracy, head of Growth and Partnerships at Enthea, shares how employers and unions can support mental health and address access barriers to evidence-based ketamine treatments.
Listen
New Insights Into H5N1 Variability in Human Mutations
Mutations in one of the first human-isolated strains of H5N1 bird flu in the US were identified by the Texas Biomedical Research Institute.
AJMC® Editors Reflect on 2024 and Look Forward to a Milestone
The editors in chief of The American Journal of Managed Care® discuss the key managed care research and news from 2024 and look forward to the journal’s upcoming 30th anniversary.
FDA Approves Datopotamab Deruxtecan for HR-Positive/HER2-Negative Metastatic Breast Cancer
The approval is based on findings from the phase 3, multicenter, open-label, randomized TROPION-Breast01 trial.
5 Medications That Defer Blood Donation
Experts stress that persons wanting to donate blood should not stop any medications they are on, with some deferrals being permanent and others temporary.